Unknown

Dataset Information

0

Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.


ABSTRACT: BACKGROUND:Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer. METHODS:Claudin-2 expression was analyzed in two independent cohorts. Cohort 1 included 304 women with metastatic breast cancer diagnosed between 2002 and 2007, while cohort 2 included 237 premenopausal women with early-stage node-negative breast cancer diagnosed between 1991 and 1994. Global transcriptional profiling of fine-needle aspirates from metastases was performed, followed by immunohistochemical analyses in archival primary tumor tissue. Associations between claudin-2 expression and relapse site were assessed by univariable and multivariable Cox regression models including conventional prognostic factors. Two-sided statistical tests were used. RESULTS:CLDN2 was significantly up-regulated (P < 0.001) in liver metastases compared to other metastatic sites. Claudin-2 protein was more frequently expressed in primary tumors from patients who subsequently developed liver metastases (P = 0.02) and high expression was associated with a shorter metastasis-free interval (cohort 1, HR = 1.4, 95% CI = 1.0-1.9; cohort 2, HR = 2.2, 95% CI = 1.3-3.5). Specifically, a significantly shorter interval between primary tumor diagnosis and liver-specific recurrence was observed among patients with high levels of claudin-2 expression in the primary tumor (cohort 1, HR = 2.3, 95% CI = 1.3-3.9). CONCLUSION:These results suggest a novel role for claudin-2 as a prognostic biomarker with the ability to predict not only the likelihood of a breast cancer recurrence, but more interestingly, the liver metastatic potential of the primary tumor.

SUBMITTER: Kimbung S 

PROVIDER: S-EPMC5528500 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Claudin-2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences.

Kimbung Siker S   Kovács Anikó A   Bendahl Pär-Ola PO   Malmström Per P   Fernö Mårten M   Hatschek Thomas T   Hedenfalk Ingrid I  

Molecular oncology 20131014 1


<h4>Background</h4>Predicting any future metastatic site of early-stage breast cancer is important as it significantly influences the prognosis of advanced disease. This study aimed at investigating the potential of claudin-2, over-expressed in breast cancer liver metastases, as a biomarker for predicting liver metastatic propensity in primary breast cancer.<h4>Methods</h4>Claudin-2 expression was analyzed in two independent cohorts. Cohort 1 included 304 women with metastatic breast cancer diag  ...[more]

Similar Datasets

| S-EPMC9234755 | biostudies-literature
| S-EPMC7575275 | biostudies-literature
| S-EPMC4686554 | biostudies-literature
| S-EPMC6923975 | biostudies-literature
| S-EPMC3832393 | biostudies-literature
2011-11-01 | E-GEOD-31311 | biostudies-arrayexpress
2011-11-01 | GSE31311 | GEO
| S-EPMC7178498 | biostudies-literature
| S-EPMC5546527 | biostudies-literature
| S-EPMC10571851 | biostudies-literature